Sirtuin deacetylases in neurodegenerative diseases of aging

Sirtuin enzymes are a family of highly conserved protein deacetylases that depend on nicotinamide adenine dinucleotide (NAD+) for their activity. There are seven sirtuins in mammals and these proteins have been linked with caloric restriction and aging by modulating energy metabolism, genomic stabil...

Full description

Bibliographic Details
Main Authors: Herskovits, A. Zara, Guarente, Leonard Pershing
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Language:en_US
Published: Nature Publishing Group 2014
Online Access:http://hdl.handle.net/1721.1/84499
https://orcid.org/0000-0002-6841-4539
https://orcid.org/0000-0003-4064-2510
_version_ 1826205191141064704
author Herskovits, A. Zara
Guarente, Leonard Pershing
author2 Massachusetts Institute of Technology. Department of Biology
author_facet Massachusetts Institute of Technology. Department of Biology
Herskovits, A. Zara
Guarente, Leonard Pershing
author_sort Herskovits, A. Zara
collection MIT
description Sirtuin enzymes are a family of highly conserved protein deacetylases that depend on nicotinamide adenine dinucleotide (NAD+) for their activity. There are seven sirtuins in mammals and these proteins have been linked with caloric restriction and aging by modulating energy metabolism, genomic stability and stress resistance. Sirtuin enzymes are potential therapeutic targets in a variety of human diseases including cancer, diabetes, inflammatory disorders and neurodegenerative disease. Modulation of sirtuin activity has been shown to impact the course of several aggregate-forming neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis and spinal and bulbar muscular atrophy. Sirtuins can influence the progression of neurodegenerative disorders by modulating transcription factor activity and directly deacetylating proteotoxic species. Here, we describe sirtuin protein targets in several aggregate-forming neurodegenerative diseases and discuss the therapeutic potential of compounds that modulate sirtuin activity in these disorders.
first_indexed 2024-09-23T13:08:48Z
format Article
id mit-1721.1/84499
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T13:08:48Z
publishDate 2014
publisher Nature Publishing Group
record_format dspace
spelling mit-1721.1/844992022-09-28T12:13:19Z Sirtuin deacetylases in neurodegenerative diseases of aging Herskovits, A. Zara Guarente, Leonard Pershing Massachusetts Institute of Technology. Department of Biology Herskovits, A. Zara Guarente, Leonard Pershing Sirtuin enzymes are a family of highly conserved protein deacetylases that depend on nicotinamide adenine dinucleotide (NAD+) for their activity. There are seven sirtuins in mammals and these proteins have been linked with caloric restriction and aging by modulating energy metabolism, genomic stability and stress resistance. Sirtuin enzymes are potential therapeutic targets in a variety of human diseases including cancer, diabetes, inflammatory disorders and neurodegenerative disease. Modulation of sirtuin activity has been shown to impact the course of several aggregate-forming neurodegenerative disorders including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis and spinal and bulbar muscular atrophy. Sirtuins can influence the progression of neurodegenerative disorders by modulating transcription factor activity and directly deacetylating proteotoxic species. Here, we describe sirtuin protein targets in several aggregate-forming neurodegenerative diseases and discuss the therapeutic potential of compounds that modulate sirtuin activity in these disorders. 2014-01-24T17:17:02Z 2014-01-24T17:17:02Z 2013-05 Article http://purl.org/eprint/type/JournalArticle 1001-0602 1748-7838 http://hdl.handle.net/1721.1/84499 Herskovits, Adrianna Z, and Leonard Guarente. “Sirtuin Deacetylases in Neurodegenerative Diseases of Aging.” Cell Research 23.6 (2013): 746–758. https://orcid.org/0000-0002-6841-4539 https://orcid.org/0000-0003-4064-2510 en_US http://dx.doi.org/10.1038/cr.2013.70 Cell Research Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License http://creativecommons.org/licenses/by-nc-nd/3.0/ application/pdf Nature Publishing Group Cell Research
spellingShingle Herskovits, A. Zara
Guarente, Leonard Pershing
Sirtuin deacetylases in neurodegenerative diseases of aging
title Sirtuin deacetylases in neurodegenerative diseases of aging
title_full Sirtuin deacetylases in neurodegenerative diseases of aging
title_fullStr Sirtuin deacetylases in neurodegenerative diseases of aging
title_full_unstemmed Sirtuin deacetylases in neurodegenerative diseases of aging
title_short Sirtuin deacetylases in neurodegenerative diseases of aging
title_sort sirtuin deacetylases in neurodegenerative diseases of aging
url http://hdl.handle.net/1721.1/84499
https://orcid.org/0000-0002-6841-4539
https://orcid.org/0000-0003-4064-2510
work_keys_str_mv AT herskovitsazara sirtuindeacetylasesinneurodegenerativediseasesofaging
AT guarenteleonardpershing sirtuindeacetylasesinneurodegenerativediseasesofaging